Table 4.
Laboratory findings of fevered COVID-19 patients with different severity.
| Normal range | Non-severe | Severe | P-value | |
|---|---|---|---|---|
| (n = 130) | (n = 45) | |||
| White blood cell count, × 109/L, median (range) | 4-10 | 4.5 (1.9-13.4) | 4.6 (0.8-10.4) | 0.604 |
| Lymphocyte count, × 109/L, median (range) | 0.8-4.0 | 1.1 (0.4-3.2) | 0.7 (0.1-1.9) | 0.000 |
| Lymphocyte %, median (range) | 20-40 | 27.5 (6.8-54.1) | 18.6 (2.1-34.2) | 0.000 |
| Alanine aminotransferase, U/L, median (range) | 0-42 | 19.7 (4.9-58.4) | 23.9 (8.2-93.7) | 0.010 |
| Aspartate aminotransferase, U/L, median (range) | 0-37 | 23.3 (2.0-59.5) | 30.6 (16.9-82.1) | 0.000 |
| Total bilirubin, μmol/L, median (range) | 3.4-20.5 | 10.9 (4.0-31.6) | 11.8 (4.7-162.1) | 0.805 |
| C reactive protein, mg/L, median (range) | 0-8 | 16.0 (0.1-91.4) | 40.8 (2.7-101.9) | 0.000 |
| Erythrocyte sedimentation rate, mm/h, median (range) | 0-15 | 46.0 (5.0-143.0) | 51.5 (9.0-129.0) | 0.208 |
| Procalcitonin, ≥0.05 ng/ml, No. (%) | <0.05 | 38 (29.2) | 16 (35.6) | 0.429 |
| Creatinine, μmol/L, median (range) | 21.5-104 | 51.3 (20.6-105.1) | 53.4 (21.9-255.7) | 0.720 |
| Creatine kinase, U/L, median (range) | 10-190 | 69.2 (11.3-365.3) | 92.0 (17.4-986.4) | 0.014 |
| Creatine kinase-MB, U/L, median (range) | 0-24 | 9.3 (0.3-221.7) | 11.2 (1.1-35.2) | 0.049 |
P < 0.05 was considered statistically significant (marked in bold). Continuous variables were described as median with range and analyzed by Mann-Whitney test. Categorical variables were described as percentages and analyzed by the χ2 test or Fisher's exact test.
Abbreviations: COVID-19, coronavirus disease 2019.